Falmina Kit
NDC Package 16714-359-01
Package Information
Falmina (levonorgestrel and ethinyl estradiol) kits is fALMINA is indicated for the use by females of reproductive potential to prevent pregnancy.Limitations of use: The efficacy of FALMINA in women with a body mass index (BMI) of > 35 kg/m2 has not been adequately evaluated.In a clinical trial with levonorgestrel and ethinyl estradiol tablets, 1,477 subjects had 7,720 cycles of use and a total of 5 pregnancies were reported. This formulation utilizes a kit delivery system. Marketed by Northstar Rx Llc, this product is identified by NDC 16714-359 and is authorized under FDA application ANDA090721.
Identification & Billing
- RxCUI: 1304988 - {21 (ethinyl estradiol 0.02 MG / levonorgestrel 0.1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Falmina 28 Day]
- RxCUI: 1304988 - FALMINA 28 Day Pack
- RxCUI: 1304988 - Falmina 28 Day Pack
- RxCUI: 242297 - levonorgestrel 0.1 MG / ethinyl estradiol 0.02 MG Oral Tablet
- RxCUI: 242297 - ethinyl estradiol 0.02 MG / levonorgestrel 0.1 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 16714 - Northstar Rx Llc
- 16714-359 - Falmina
- 16714-359-01 - 1 BLISTER PACK in 1 PACKET / 1 KIT in 1 BLISTER PACK
- 16714-359 - Falmina
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (16714-359). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 16714-359-01 identifies a specific commercial package of 1 blister pack in 1 packet / 1 kit in 1 blister pack of Falmina, a human prescription drug labeled by Northstar Rx Llc. This kit is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Northstar Rx Llc on September 13, 2013. The current certification is valid through December 31, 2026.
How is this Northstar Rx Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 16714035901. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.